Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Capricor Therap (NQ: CAPR )

3.490 -0.270 (-7.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 204,320
Open 3.690
Bid (Size) 3.450 (3)
Ask (Size) 3.500 (13)
Prev. Close 3.760
Today's Range 3.454 - 3.720
52wk Range 2.560 - 5.850
Shares Outstanding 24,324,156
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Undervalued Penny Stocks With Major Upside
Each of these penny stocks has proven momentum throughout 2022 and major upside on top of the returns through the the first quarter. 
Via InvestorPlace
50 Biggest Movers From Yesterday
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in... 
Via Benzinga

Performance

YTD
+9.75%
+9.75%
1 Month
-3.86%
-3.86%
3 Month
+1.75%
+1.75%
6 Month
+16.33%
+16.33%
1 Year
-31.97%
-31.97%

More News

Read More
Mid-Afternoon Market Update: Dow Drops 150 Points; Capricor Therapeutics Shares Plunge
Via Benzinga
Earnings Scheduled For March 10, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Capricor Shares Fall After Topline Results From Mid-Stage COVID-19 Trial
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Capricor Stops Work On Exosome-mRNA Based COVID-19 Vaccine Candidate
Via Benzinga
Capricor Therapeutics: Q4 Earnings Insights
Via Benzinga
Earnings Outlook For Capricor Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
51 Biggest Movers From Yesterday
Via Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Capricor Therapeutics, Nippon Shinyaku Ink US Pact For Duchenne Muscular Dystrophy Candidate
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
50 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Capricor Stock Is Moving Higher As Duchenne Dystrophy Cell Therapy Slows Disease Progression By 71%
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.